posts tagged as Drug pricing
BDO’s 2018 Life Sciences Outlook
BDO’s Life Sciences practice makes four predictions for the industry in 2018, including that mainstream milestone-based reimbursements and a biotech M&A recovery are coming.
Healthcare Reform: Insights from Inside the Beltway
We recently hosted a breakfast panel, Healthcare Reform: Insights from Inside the Beltway, during the 2017 J.P. Morgan Healthcare Conference, featuring our senior fellow, Dr. Scott Gottlieb, and Dave Tamasi of Rasky Baerlein, along with...